Hannover cohort | Kiel cohort | |||
---|---|---|---|---|
Indication | Number of patients (% of cohort) | Indication | Number of patients (% of cohort) | |
1 | Viral hepatitis | 334 (13.0%) | Alcoholic cirrhosis | 119 (20.5%) |
2 | Hepatocellular carcinoma | 281 (11.0%) | Viral hepatitis | 86 (14.8%) |
3 | Acute liver failure | 246 (9.6%) | Hepatocellular carcinoma | 43 (7.4%) |
4 | Primary sclerosing cholangitis | 196 (7.7%) | Biliary atresia | 41 (7.1%) |
5 | Biliary atresia | 192 (7.5%) | Acute liver failure | 36 (6.2%) |